Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP643531.RAuc2oMJfRdVMyjle5eQ7zW0thQ_MnTMSnD3XvW23jJis130_assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643531.RAuc2oMJfRdVMyjle5eQ7zW0thQ_MnTMSnD3XvW23jJis130_provenance.
• NP675934.RAawyatBPWUK6hv-NWDYSeCQmEvZNQY2Sno3SI9wmrYqM130_assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675934.RAawyatBPWUK6hv-NWDYSeCQmEvZNQY2Sno3SI9wmrYqM130_provenance.
• NP780913.RA4QNRKzLOdbmR5DkD3j4Ps4jkzxIwNstp0lLZg5o5t8c130_assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP780913.RA4QNRKzLOdbmR5DkD3j4Ps4jkzxIwNstp0lLZg5o5t8c130_provenance.
• NP917820.RA-RDPPz2PuWjYq3NgToQq4jMCtXObBNio51ekqMa1eDs130_assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917820.RA-RDPPz2PuWjYq3NgToQq4jMCtXObBNio51ekqMa1eDs130_provenance.
• NP484569.RAV3kmeOi62Ld87hPs_yzGDsk0AVYMvY8yHYlTcPKIPT4130_assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP484569.RAV3kmeOi62Ld87hPs_yzGDsk0AVYMvY8yHYlTcPKIPT4130_provenance.
• assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP304576.RAZ2gFyeSyKgHN8j0lKKx4MCGfWbYp9b0xCKvuM5OcU6Q130_assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304576.RAZ2gFyeSyKgHN8j0lKKx4MCGfWbYp9b0xCKvuM5OcU6Q130_provenance.
• NP304579.RATQmzl2RWJupwFqW8cHsUI8BqKYCKdWBwbksAnNxBcmI130_assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304579.RATQmzl2RWJupwFqW8cHsUI8BqKYCKdWBwbksAnNxBcmI130_provenance.
• NP484567.RAqFz3YHr_113tDihUzqJ8V28a7AQ_HY-3fVzlfP85_40130_assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP484567.RAqFz3YHr_113tDihUzqJ8V28a7AQ_HY-3fVzlfP85_40130_provenance.
• NP304575.RAvsdYcnsaNvRWhMvLwhulL5dXWmxlXlEaMW2f5YA9Jqo130_assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304575.RAvsdYcnsaNvRWhMvLwhulL5dXWmxlXlEaMW2f5YA9Jqo130_provenance.
• NP304577.RAno-FTNTb6JJG4b5DvTQ94TZxDO_x_HXKYxM3F6LSYQs130_assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304577.RAno-FTNTb6JJG4b5DvTQ94TZxDO_x_HXKYxM3F6LSYQs130_provenance.
• NP481896.RAydiGn_pigV5jjV6a8SnSY6p8yB4yvQNzAP7Awpg-xP8130_assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP481896.RAydiGn_pigV5jjV6a8SnSY6p8yB4yvQNzAP7Awpg-xP8130_provenance.
• NP484626.RAyuL3Up0WtcZFMbDmPMPABiACJq9QzhsCWhcK0cpB5jI130_assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP484626.RAyuL3Up0WtcZFMbDmPMPABiACJq9QzhsCWhcK0cpB5jI130_provenance.
• NP304580.RANtTjfJgQbrwTpH5CqmrqUh-AvLljGAwEoblWG6SwVr8130_assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304580.RANtTjfJgQbrwTpH5CqmrqUh-AvLljGAwEoblWG6SwVr8130_provenance.
• NP304578.RAzXqRAhz-vel_Gybga9oMOEoNMqu8OhMnudxwiXV6qk0130_assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304578.RAzXqRAhz-vel_Gybga9oMOEoNMqu8OhMnudxwiXV6qk0130_provenance.